Healthcare finance

Bridges JM, Jacobs P. Obtaining estimates of marginal cost by DRG. Healthcare Financ Manage 1986 40 40-6. 

Kanavos P. Pricing and Reimbursement in Europe. Richmond, Surrey, U.K. PJB Publications, 2002. In this Scrip Report, Kanavos analyzes important trends in healthcare financing provisions and reform. Coverage includes a critical appraisal of regulations affecting pricing and reimbursement in both EU and other countries in the region. The book is published in both hardcopy and electronic format (HTML or PDF subscriptions). 

Health Economics Information Resources A Self-Study Course. URL http //www.nlm.nih.gov/nichsr/edu/healthecon/ index.html (accessed October 2005). This online course describes the scope of health economics and its key information resources highlights the sources and characteristics of healthcare financing information in the United States outlines issues relating to the quality of health economic evaluation studies and guides users in the identification, retrieval, and assessment of high quality health economic evaluation studies and related publications. The course contains a detailed bibliography of related sources. 

Healthcare financing is changing and evolving with time, with a continuous decline in reimbursement, while the cost of healthcare itself is growing. It is absolutely critical to attempt to maximize collection of reimbursement for each study, and this can be achieved only through understanding of codes for each study, providing proper codes and other information in the claim form, and appropriate follow-up in the case of rejection or incorrect payment. 

With the planned consolidation of the top four U.S. dialysis providers into two vertically integrated companies, the field of available dialyzers is likely to narrow. Meanwhile, the decrease in dialyzer reuse will continue to drive increased production. Given that the Center for Medicare and Medicaid Services (CMS), formerly known as the Healthcare Financing Administration (HCFA), will continue its downward pressure on costs, and possibly institute a capitated payment system (i.e., a fixed monthly payment to cover all patient costs including hospitalization), only incremental improvements in commercially available dialyzer membranes are expected in the next 5 years. 

Incorrect I m committed to finding innovative solutions to the problems that prevent nations from achieving increases in productivity, ensuring quality healthcare for it s citizens and easing barriers to private enterprise. Specifically, I ve an interest in finance and micro-enterprise development. 

The remaining are the National Institutes of Health, the Centers for Disease Control and Prevention, the Agency for Toxic Substances and Disease Registry, the Indian Health Service, the Health Resources and Services Administration, the Substance Abuse and Mental Health Services Administration, the Agency for Healthcare Research and Quality, the Health Care Financing Administration, the Administration for Children and Families, and the Administration on Aging. 

The ministries involved are the Ministries of Health, Social Security, Economy and Finance, and Industry. Under the supervision of the Ministry of Health (which is a member of the Economic Committee for Medicines) are the Medicines Agency, the Agency for Healthcare and Health Products, and the French Blood Establishment. 

A MCO is any type of system that integrates the financing and delivery of healthcare to voluntarily enrolled plan members. Common distinguishing characteristics of MCOs include... 

The purpose of the Agency is to enhance the quality, appropriateness, and effectiveness of healthcare services, and access to such services, through the establishment of a broad base of scientific research and through the promotion of improvements in clinical practice and in the organization, financing, and delivery of healthcare services. 

Health services research (HSR) is a relatively new and evolving field. As the organization and financing of healthcare has changed, the need for information about the type and level of care and the effectiveness and quality of care provided in the healthcare system has increased. This chapter provides a definition of HSR, a historical perspective of the development of-the field and the relationship between HSR and public health policy, and a discussion of the profession of pharmacy and its relationship to HSR. The chapter concludes by highlighting some of the institutions that commonly fund HSR and journals that publish manuscripts on HSR topics. 

The following three reports built on this initial framework. Each provided an updated snapshot of the evolving healthcare system in the United States including sections on access, quality, financing, and satisfaction. These sections were generally followed by observations and general recommendations to the healthcare and health profession education systems, followed by specific recommendations to individual professions. 

Sandra Ferconio Michael Lane, Financing Maneuvers Two Opportunities to Boost a Hospital s Working Capital, Healthcare Fin. Mgmt., Oct. 1991, at 74. 

Healthcare providers (physicians, hospitals, clinics, etc.) operate and are sustained by the reimbursement or payment for care they provide to patients. In the United States, revenue for healthcare services comes from a variety of sources including the patient, insurance companies (i.e., Blue-Cross/BlueShield, Cigna, Aetna), and the Centers for Medicare and Medicaid Services (CMS), formerly the Health Care Financing Administration (HCFA). The CMS provides healthcare insurance for Medicare and Medicaid beneficiaries. When interfacing with an insurance company or the CMS, there are three fundamental reimbursement concepts that must be considered to assure appropriate revenue for services provided. These include the concepts of coverage, coding, and payment. 

---